Towelettes to kill MRSA

Link: Veridien Corporation

In addition to the Hepatitis A, B and C kill claims, the Viraguard(R) Disinfectant Towelettes now carry all the viral and bacterial kill claims of the Viraguard(R) liquid disinfectants, including Methicillin-resistant Staphylococcus Aureus (MRSA), Vancomycin-resistant Enterococcus Faecalis (VRE), Herpes Simplex-type 1 and 2, Escheria coli (E.coli) strain 157, Mycobacterium bovis (BCG, TB surrogate), Pseudomonas aeruginosa, Streptococcus Pyogenes, Salmonella choleraesius, Staphylococcus aureus, Respiratory syncytial virus (RSV), Rotavirus (SA-11 Group A), Influenza Hong Kong type 1 and 2, HIV-1 (aids virus), Trichophyton mentagrophytes (athlete's foot fungus), Cytomegalovirus (CMV) and Adenovirus Type 2. Paul Dunnigan, VP-Marketing Group, "This is outstanding news for our healthcare, industrial and retail clientele. With the new EPA approved label claims, Viraguard(R) Infection Control Products provide our customers with the full Hepatitis and anti-viral protection they need in surface disinfecting wipes as well as in liquid disinfectants. We offer them equal protection for hand sanitizing by using the same tested, safe and effective formula in our hand antiseptic products. In particular, Veridien's products are critical in helping to control orally transmitted pathogens (Hepatitis A) and blood-borne pathogens (Hepatitis C) that threaten food workers, emergency medical workers, clinicians and physicians worldwide. Veridien's strategic multi-national client and distributors regard the anti-viral kill claims as a distinct advantage to leverage large contracts in the health and safety industry."